Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Category
US Equities - Industry Sector
Sponsor
Invesco
Fund Family
Index
Dynamic Pharmaceuticals Intellidex Indx
Index Weighting
Active/Passive
Expense
0.58%
Inverse/Leveraged
IPO
Jun 23, 2005
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
1.19%
SMA50
-0.64%
SMA200
9.77%
Return% 1Y
33.13%
Return% 3Y
21.67%
Return% 5Y
11.10%
Return% 10Y
Return% SI
Flows% 1M
-0.85%
Flows% 3M
17.10%
Flows% YTD
45.39%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
30
AUM
555.09M
NAV/sh
52W High
131.68 -5.05%
52W Low
94.89 31.77%
Volatility
1.40% 1.50%
ATR (14)
2.05
RSI (14)
51.58
Beta
0.45
Rel Volume
0.00
Avg Volume
35.60K
Volume
0
Perf Week
0.46%
Perf Month
-1.14%
Perf Quarter
3.67%
Perf Half Y
20.24%
Perf YTD
19.60%
Perf Year
31.50%
Perf 3Y
79.41%
Perf 5Y
59.09%
Perf 10Y
112.93%
Prev Close
125.03
Price
125.03
Change %
0.00%
Invesco Dynamic Pharmaceuticals ETF seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.